| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.75B | 38.70B | 35.08B | 31.68B | 28.14B | 24.68B |
| Gross Profit | 23.09B | 22.99B | 21.00B | 18.70B | 16.17B | 13.60B |
| EBITDA | 6.99B | 7.23B | 6.47B | 5.40B | 4.52B | 3.26B |
| Net Income | 4.05B | 4.32B | 3.65B | 3.13B | 2.55B | 1.67B |
Balance Sheet | ||||||
| Total Assets | 50.18B | 49.99B | 50.09B | 43.73B | 40.71B | 37.81B |
| Cash, Cash Equivalents and Short-Term Investments | 9.96B | 10.89B | 9.72B | 9.58B | 9.06B | 6.94B |
| Total Debt | 1.87B | 213.00M | 281.00M | 1.19B | 1.48B | 1.87B |
| Total Liabilities | 7.51B | 7.26B | 8.48B | 8.21B | 7.77B | 7.62B |
| Stockholders Equity | 42.58B | 42.66B | 41.53B | 35.44B | 32.87B | 30.14B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.22B | 1.38B | 1.54B | 2.67B | 1.73B |
| Operating Cash Flow | 0.00 | 3.45B | 3.09B | 3.17B | 3.74B | 2.83B |
| Investing Cash Flow | 0.00 | -914.00M | -1.29B | -1.29B | -1.29B | -4.08B |
| Financing Cash Flow | 0.00 | -1.78B | -2.10B | -1.46B | -1.07B | 3.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥49.30B | 11.67 | ― | 3.22% | 12.92% | 29.48% | |
74 Outperform | ¥122.10B | 23.55 | 5.97% | 1.78% | 3.17% | 7.07% | |
69 Neutral | ¥66.73B | 14.61 | ― | 2.83% | 3.69% | 1.86% | |
68 Neutral | ¥145.61B | 31.36 | ― | 2.73% | 5.10% | -26.13% | |
67 Neutral | ¥17.65B | 12.83 | ― | 2.65% | 0.81% | -26.76% | |
59 Neutral | ¥144.24B | 257.57 | 0.78% | 1.31% | -2.06% | -79.17% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
Shofu Inc. has announced partial amendments to its shareholder benefits plan, primarily to streamline operations and align logistics, by unifying the shipment period for complimentary company products to late June each year. The company is also revising the preferential pricing within the shareholder plan for its medicated liquid toothpaste “Hapica Ace” in line with a broader price revision, while maintaining the range of eligible shareholders and the core lineup of dental care products offered at discounted rates, a move aimed at improving administrative efficiency and sustaining the attractiveness of its benefits program for investors.
The most recent analyst rating on (JP:7979) stock is a Hold with a Yen2079.00 price target. To see the full list of analyst forecasts on Shofu Inc. stock, see the JP:7979 Stock Forecast page.
Shofu Group has unveiled a new long-term vision, “Vision10,” targeting a position among the world’s top 10 dental companies by 2040 with group revenue of ¥250 billion and an operating margin of 20%. Building on its current medium-term plan and responding to structural shifts in the global dental industry—such as demographic change, rising preventive care, and digitalization—the company plans to strengthen its foundation in restorative materials, accelerate global expansion in areas including digital dentistry, preventive and oral care, and orthodontics, and move into adjacent fields such as periodontal care, regenerative medicine, and education, with the aim of transforming its growth profile and deepening its contribution to global dental healthcare.
The most recent analyst rating on (JP:7979) stock is a Hold with a Yen2079.00 price target. To see the full list of analyst forecasts on Shofu Inc. stock, see the JP:7979 Stock Forecast page.
Shofu Inc. announced a personnel change effective January 1, 2026, with Shinya Teramoto being appointed as Managing Executive Officer, Personnel and General Affairs, and General Manager of the General Affairs Department. This change reflects the company’s ongoing efforts to strengthen its leadership team and enhance operational efficiency.
The most recent analyst rating on (JP:7979) stock is a Hold with a Yen2079.00 price target. To see the full list of analyst forecasts on Shofu Inc. stock, see the JP:7979 Stock Forecast page.
Shofu Inc. reported a slight increase in consolidated net sales for the first half of the fiscal year ending March 2026, with a 1.1% year-over-year growth. The dental business remains a major contributor to sales, although there was a minor decline in overseas sales. The company also noted a significant increase in R&D expenses, indicating a focus on innovation and product development.
The most recent analyst rating on (JP:7979) stock is a Hold with a Yen2079.00 price target. To see the full list of analyst forecasts on Shofu Inc. stock, see the JP:7979 Stock Forecast page.
Shofu Inc. reported its consolidated financial results for the six months ending September 30, 2025, showing a slight increase in net sales by 1.1% to 19,095 million yen. However, operating income decreased by 7.5% compared to the previous year. The company experienced a significant rise in comprehensive income by 313.2% to 2,896 million yen, indicating improved profitability despite the decline in operating income. The company also noted a two-for-one stock split, affecting the calculation of earnings per share. The financial outlook for the fiscal year ending March 31, 2026, projects a 5.6% increase in net sales, with a slight decrease in operating and ordinary income, but an 8.9% increase in net income attributable to owners of the parent.
The most recent analyst rating on (JP:7979) stock is a Hold with a Yen2079.00 price target. To see the full list of analyst forecasts on Shofu Inc. stock, see the JP:7979 Stock Forecast page.
Shofu Inc. has revised its earnings forecast for the first half of the fiscal year ending March 31, 2026, due to lower-than-expected demand in Japan and challenging overseas business conditions. Despite a decrease in net sales, the company anticipates higher operating and ordinary income due to deferred expenses and increased net income from the early sale of cross-shareholdings. The full-year earnings forecast remains unchanged, with the company aiming to maintain profitability while monitoring the business environment.
The most recent analyst rating on (JP:7979) stock is a Buy with a Yen2171.00 price target. To see the full list of analyst forecasts on Shofu Inc. stock, see the JP:7979 Stock Forecast page.